Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

NewGen Therapeutics: Activity of Targeted Anti-Cancer Drug

December 16, 2014 9:47 am | News | Comments

NewGen Therapeutics, Inc. announced the publication of preclinical research strongly supporting NT-113, the company's novel irreversible pan-erbB inhibitor (EGFR, HER2 and HER4), as a potential new treatment for glioblastoma multiforme (GBM), the most common and most aggressive malignant primary brain tumor in adults. Read more...

TOPICS:

Neovacs Announces Clinical Trial Results for RA Drug

December 16, 2014 9:35 am | News | Comments

Neovacs, a leader in active immunotherapies for the treatment of autoimmune diseases, announced top line data on the Phase IIb clinical trial of TNF-Kinoid in Rheumatoid Arthritis (RA). Read more...                                                

Pfizer: Breast Cancer Treatment Results

December 16, 2014 9:17 am | News | Comments

Pfizer Inc. announced the publication of the detailed results from PALOMA-1, a randomized Phase 2 study of palbociclib in combination with letrozole versus letrozole alone, in The Lancet Oncology.  Read more...             

TOPICS:
Advertisement

Women in Cell Biology Award Winners Announced at ASCB Meeting

December 15, 2014 4:47 pm | by Stephanie Guzowski, Editor | Articles | Comments

Three exceptional women were given awards for their achievements and contributions to the scientific community at the 2014 ASCB (American Society for Cell Biology) meeting recently held in Philadelphia, Pa. Read more...                               

TOPICS:

Going After Colon Cancer With Strep Bacteria

December 15, 2014 2:19 pm | by Skip Derra, Contributing Writer | Articles | Comments

A novel therapeutic to fight colon cancer by using the bacteria primarily responsible for causing strep throat is being explored in the labs of John McCormick of the Schulich School of Medicine & Dentistry at the University of Western Ontario, London, Ontario, Canada. Read more...

TOPICS:

Study Shows Potential for Faster Drug Development

December 15, 2014 1:47 pm | News | Comments

A new study demonstrates the ability to conduct robust cardiac safety characterizations several years earlier than current practice. Read more...                    

TOPICS:

FDA Approves Drug That Extends Lung Cancer Survival

December 15, 2014 1:37 pm | by University of California, Los Angeles | News | Comments

The FDA approved a new drug to treat non-small-cell lung cancer offering people new hope in fighting the disease. Read more...                       

TOPICS:

FDA Approves Drug That Extends Lung Cancer Survival

December 15, 2014 1:36 pm | by University of California, Los Angeles | News | Comments

The FDA approved a new drug to treat non-small-cell lung cancer offering people new hope in fighting the disease. Read more...                       

TOPICS:
Advertisement

Scientists Reveal Neurotransmitter Binding-Site Function

December 15, 2014 1:15 pm | by Ellen Goldbaum, University of Buffalo | News | Comments

New research from University at Buffalo scientists will help pharmacologists better understand how drugs work and how to make them more effective. Read more...                 

TOPICS:

Medication Being Studied Could Help Afib Patients After Stroke

December 15, 2014 1:03 pm | by University of South Florida | News | Comments

Researchers are studying the effectiveness of a new rapid-onset anticoagulant medication with the standard anticoagulant drug in stroke patients with atrial fibrillation, the most common type of abnormal heart rhythm. Read more...     

TOPICS:

Cancer Patients Testing Drugs on Mouse Avatars

December 15, 2014 12:56 pm | by Marilynn Marchione - AP Chief Medical Writer | News | Comments

The idea is to see which drugs might work best on a specific person's specific cancer. Read more...                           

TOPICS:

Anthera Licenses Japan Rights for Blisibimod to Zenyaku

December 15, 2014 11:11 am | News | Comments

Anthera Pharmaceuticals, Inc. announced that Anthera and Zenyaku Kogyo Co., Ltd. of Tokyo, Japan executed an exclusive license agreement for the development and commercialization of subcutaneous blisibimod in Japan and potentially other countries throughout Asia.  Read more...

TOPICS:

Tackling One of The Biggest Questions in Dementia Research

December 15, 2014 11:06 am | by University of Southampton | News | Comments

Researchers in Southampton are tackling one of the biggest questions in dementia research; why might current approaches in Alzheimer's trials be failing? The new study is published in the Journal of Pathology and funded by Alzheimer's Research UK and the Medical Research Council. Read more...

TOPICS:

UN Commission Asks for Ebola Debt Forgiveness

December 15, 2014 11:00 am | by Associated Press | News | Comments

A U.N. commission is asking for more debt cancellations for the three West African nations hardest hit by the Ebola virus. The United Nations Economic Commission for Africa said that it is crucial that the current Ebola health crisis not be a catalyst for financial distress in Sierra Leone, Guinea and Liberia. Read more..

TOPICS:

Roche Expands CE-IVD Claims For Organ, Tissue Testing

December 15, 2014 10:55 am | News | Comments

Roche announced that the cobas MPX and cobas WNV assays can now be used for testing of human organ and tissue from cadaveric (non-heart beating) donors, expanding the range of approved uses for the cobas 6800/8800 Systems and assays in markets accepting the CE mark. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading